Prostatic Neoplasms
Information
- Disease name
- Prostatic Neoplasms
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT06104449 | Active, not recruiting | Phase 1 | A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005) | November 14, 2023 | January 12, 2026 |
| NCT05288166 | Active, not recruiting | Phase 3 | A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) | April 14, 2022 | October 2027 |
| NCT03523442 | Active, not recruiting | Phase 1 | A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer | August 31, 2018 | June 30, 2024 |
| NCT04108208 | Active, not recruiting | Phase 4 | A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC) | December 17, 2019 | June 5, 2026 |
| NCT04034095 | Active, not recruiting | A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan | July 8, 2019 | October 8, 2025 | |
| NCT05999968 | Active, not recruiting | Phase 1 | Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment | January 12, 2024 | July 2026 |
| NCT04024475 | Active, not recruiting | Prostate Cancer Biobank | November 4, 2014 | November 2029 | |
| NCT06151418 | Active, not recruiting | A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces | November 22, 2023 | October 31, 2024 | |
| NCT03007732 | Active, not recruiting | Phase 2 | Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT | May 17, 2017 | October 31, 2024 |
| NCT05150236 | Active, not recruiting | Phase 2 | EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC | April 29, 2022 | December 2024 |
| NCT04689828 | Active, not recruiting | Phase 3 | 177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer | June 15, 2021 | September 30, 2025 |
| NCT02531516 | Active, not recruiting | Phase 3 | An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS | November 19, 2015 | December 29, 2028 |
| NCT04652973 | Active, not recruiting | Evaluation of Atherosclerotic Plaques in Abdominal CT Studies | November 19, 2020 | August 30, 2030 | |
| NCT02446444 | Active, not recruiting | Phase 3 | Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer | March 2014 | December 2025 |
| NCT02446405 | Active, not recruiting | Phase 3 | Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer | March 2014 | December 2024 |
| NCT03834493 | Active, not recruiting | Phase 3 | Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641) | July 28, 2019 | May 31, 2024 |
| NCT02266745 | Active, not recruiting | Phase 2 | A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts | July 2014 | April 1, 2025 |
| NCT02257736 | Active, not recruiting | Phase 3 | An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC) | November 26, 2014 | December 31, 2025 |
| NCT02123758 | Active, not recruiting | Phase 1 | A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer | July 9, 2014 | December 31, 2024 |
| NCT00579163 | Active, not recruiting | Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers | December 1994 | December 2024 | |
| NCT03824275 | Active, not recruiting | Phase 2/Phase 3 | 18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer | February 12, 2019 | December 2023 |
| NCT01946204 | Active, not recruiting | Phase 3 | A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer | October 14, 2013 | December 31, 2025 |
| NCT04736199 | Active, not recruiting | Phase 3 | Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer | February 23, 2021 | September 26, 2025 |
| NCT04577833 | Active, not recruiting | Phase 1 | A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer | November 13, 2020 | December 5, 2025 |
| NCT04461509 | Active, not recruiting | Phase 2 | High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy | April 6, 2021 | September 30, 2024 |
| NCT01653925 | Active, not recruiting | N/A | Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression | November 2010 | December 2024 |
| NCT01550237 | Active, not recruiting | N/A | Curative Image Guided Radiotherapy for Prostate Cancer | October 2012 | September 2025 |
| NCT04720157 | Active, not recruiting | Phase 3 | An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC | June 9, 2021 | February 11, 2026 |
| NCT05022849 | Active, not recruiting | Phase 1 | A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants | September 28, 2021 | June 30, 2037 |
| NCT03822845 | Active, not recruiting | Phase 2/Phase 3 | Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer | March 1, 2019 | December 31, 2028 |
| NCT03767244 | Active, not recruiting | Phase 3 | A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy | June 11, 2019 | July 19, 2029 |
| NCT04249947 | Active, not recruiting | Phase 1 | P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) | February 28, 2020 | September 2036 |
| NCT03565835 | Active, not recruiting | Phase 2 | Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer | June 13, 2018 | January 17, 2023 |
| NCT04430192 | Active, not recruiting | Phase 1/Phase 2 | Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy | August 6, 2020 | December 30, 2023 |
| NCT01464216 | Active, not recruiting | MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness | October 2011 | December 2030 | |
| NCT00160979 | Active, not recruiting | Phase 2 | Transrectal Tumour Oxygen - US Army | January 2001 | January 2028 |
| NCT04452136 | Approved for marketing | Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer | |||
| NCT00188786 | Completed | Phase 2 | Cone Beam CT for Daily Image Guidance - Prostate Cancer | April 2005 | April 2010 |
| NCT00188799 | Completed | Phase 2 | Xray Volume Imaging (Cone Beam CT) - Prostate Cancer | November 2003 | November 2004 |
| NCT00230386 | Completed | Phase 1/Phase 2 | Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma | May 2003 | |
| NCT00230438 | Completed | Phase 2 | External Beam Radiation Therapy - Target Volume | January 2005 | May 2013 |
| NCT00235794 | Completed | N/A | An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients | January 2004 | September 2007 |
| NCT00242138 | Completed | Phase 2 | Erectile Dysfunction/Prostate/RT/Androgen | March 2000 | April 2004 |
| NCT00250224 | Completed | Phase 1 | Prostate Localization During Radiotherapy Using a Ni-Ti Stent and Electronic Portal Imaging - Protocol II | January 2006 | May 2014 |
| NCT00253916 | Completed | N/A | Exercise in Men Receiving Radiation Therapy for Prostate Cancer. | June 2002 | July 2009 |
| NCT00268710 | Completed | Phase 2 | Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC] | February 2004 | March 2006 |
| NCT00271687 | Completed | Phase 2 | A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer | February 2006 | November 2007 |
| NCT00280098 | Completed | Phase 4 | Docetaxel in the Treatment of Hormone Refractory Prostate Cancer | January 2006 | |
| NCT00283062 | Completed | Phase 3 | Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy | December 2005 | December 2010 |
| NCT00291005 | Completed | Phase 2 | PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone | August 2004 | |
| NCT00302471 | Completed | Phase 1 | MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011) | March 2006 | October 2007 |
| NCT00313781 | Completed | Phase 2 | Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC) | May 2006 | December 2011 |
| NCT00373308 | Completed | Quality of Life Following Radical Prostatectomy | September 2002 | December 25, 2020 | |
| NCT00378482 | Completed | Phase 2 | A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued. | March 5, 2007 | October 27, 2023 |
| NCT00401765 | Completed | Phase 1 | A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate Cancer | September 2005 | November 2009 |
| NCT00403221 | Completed | Phase 1 | Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer | August 2006 | April 2011 |
| NCT00406939 | Completed | Phase 1 | Vector Delivery of the IL-12 Gene in Men With Prostate Cancer | June 1998 | December 2007 |
| NCT00417079 | Completed | Phase 3 | XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer | January 2007 | September 2009 |
| NCT00436839 | Completed | Phase 3 | Taxotere Prostate Cancer New Indication Registration Trial in China | January 2007 | June 2012 |
| NCT00446836 | Completed | Phase 2 | Efficacy and Safety Study of Xyotax to Treat Prostate Cancer | March 2005 | January 2008 |
| NCT00446901 | Completed | N/A | Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression | June 2007 | January 2011 |
| NCT00448409 | Completed | Phase 2 | Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer | May 2006 | May 2007 |
| NCT00473512 | Completed | Phase 1/Phase 2 | A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy | November 2005 | November 2008 |
| NCT00476645 | Completed | Phase 2 | Fulvestrant in Hormone Refractory Prostate Cancer | September 2006 | December 2009 |
| NCT00485303 | Completed | Phase 2 | An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy | June 2007 | October 2011 |
| NCT00489905 | Completed | N/A | Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer | April 2005 | May 2008 |
| NCT00519285 | Completed | Phase 3 | Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer | August 2007 | April 2012 |
| NCT00537381 | Completed | Phase 2 | An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate Cancer | May 2007 | November 2009 |
| NCT00551044 | Completed | N/A | Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer | August 2003 | August 2005 |
| NCT00564928 | Completed | Phase 2 | A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer | November 2007 | July 2010 |
| NCT00568516 | Completed | Phase 2 | Phase II Study of ASP3550 in Patients With Prostate Cancer | October 2007 | October 2009 |
| NCT00569153 | Completed | Phase 1/Phase 2 | Safety Study of TAK-700 in Subjects With Prostate Cancer. | April 2008 | February 2013 |
| NCT00630188 | Completed | N/A | Shared Decision Making for Prostate Cancer Screening: a Practice-Based Randomized Controlled Trial | March 2005 | April 2006 |
| NCT00638690 | Completed | Phase 3 | Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy | May 2008 | October 2012 |
| NCT00643617 | Completed | N/A | CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry | October 22, 2007 | April 7, 2022 |
| NCT00643994 | Completed | N/A | CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution | December 2007 | January 27, 2021 |
| NCT00667537 | Completed | Phase 1 | PK in Pts With HRPC & Skeletal Metastes | July 2007 | December 2008 |
| NCT00692107 | Completed | Phase 3 | Radiotherapy for Prostate Cancer: Conventional Dose Versus High Dose | June 1997 | December 2007 |
| NCT00706498 | Completed | Phase 2 | Phase II Study of BI 2536 in Prostate Cancer | September 2006 | |
| NCT00706628 | Completed | Phase 2 | A Multi-centre 3-arm Randomised Phase II Trial of BIBF 1120 Versus BIBW 2992 Versus Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Hormone-resistant Prostate Cancer | March 2006 | |
| NCT00744497 | Completed | Phase 3 | Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer | October 2008 | July 2015 |
| NCT00744549 | Completed | Phase 2 | Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance | May 2008 | December 2013 |
| NCT00748358 | Completed | Phase 2 | An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer | March 2008 | April 2011 |
| NCT00817739 | Completed | Phase 2 | Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c | December 1996 | December 2008 |
| NCT00822952 | Completed | Prostate Mechanical Imager (PMI) Clinical Bridging Study | October 2008 | September 2009 | |
| NCT00844792 | Completed | Phase 2 | Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer | October 2008 | December 2013 |
| NCT00853710 | Completed | N/A | Test Semiquantitative Prostate Specific Antigen (PSA) | March 2009 | July 2009 |
| NCT00855647 | Completed | Phase 2 | Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT) | August 2003 | July 2009 |
| NCT00878436 | Completed | Phase 1/Phase 2 | Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration | June 2009 | July 2015 |
| NCT00900614 | Completed | Phase 1 | Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate Cancer | May 2009 | October 2010 |
| NCT00917748 | Completed | Phase 3 | Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF) | June 2009 | March 2011 |
| NCT00962494 | Completed | Phase 2 | Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors | July 2009 | December 2011 |
| NCT01023529 | Completed | Symptoms and Quality of Life (QoL) After Palliative Pelvic Radiation of Prostate and Rectal Cancers | November 2009 | July 2015 | |
| NCT01024959 | Completed | N/A | Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy Result | August 2009 | April 2010 |
| NCT01080352 | Completed | Phase 2 | Vitamin C as an Anti-cancer Drug | November 2010 | March 2015 |
| NCT01086683 | Completed | Phase 2/Phase 3 | Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation Course | May 2004 | December 2009 |
| NCT01095848 | Completed | Phase 1 | A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer | March 2010 | November 2011 |
| NCT01186484 | Completed | Phase 1 | Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate Cancer | June 1, 2010 | October 2, 2014 |
| NCT01198457 | Completed | Study to Investigate Adherence of Patients to Clodronate (Bonefos) Treatment | January 2009 | June 2010 | |
| NCT01206036 | Completed | Phase 1/Phase 2 | CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS) | July 2010 | October 2015 |
| NCT01261572 | Completed | Phase 2 | Study to Find Maintenance Dose for Periodic Administration of ASP3550 | October 12, 2010 | April 24, 2012 |
| NCT01288911 | Completed | Phase 2 | A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer | March 22, 2011 | November 8, 2017 |
| NCT01296217 | Completed | N/A | Sentinel Lymph Node Detection in Prostate Surgery by Laparoscopy | ||
| NCT01306890 | Completed | A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer | January 27, 2011 | January 17, 2017 | |
| NCT01347476 | Completed | Aggressive Prostate Cancers in Elderly Patients | January 2010 | October 2010 | |
| NCT01357512 | Completed | N/A | Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate Cancer | April 2011 | September 2017 |
| NCT03572387 | Completed | Phase 2 | A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment | August 20, 2018 | July 8, 2022 |
| NCT00001382 | Completed | Phase 1 | A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate | March 1994 | March 2000 |
| NCT00007540 | Completed | Study of Prostate Cancer in Black and White U.S. Veterans | April 1998 | September 2000 | |
| NCT00031187 | Completed | Phase 2 | Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer | October 2000 | July 2003 |
| NCT00032825 | Completed | Phase 1 | Ketoconazole Plus Docetaxel to Treat Prostate Cancer | March 19, 2002 | June 13, 2011 |
| NCT00035113 | Completed | Phase 2 | EPO906 Therapy in Patients With Prostate Cancer | January 2002 | January 2004 |
| NCT00036556 | Completed | Phase 3 | Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer | June 2001 | |
| NCT00038662 | Completed | Phase 2 | Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure | May 2002 | |
| NCT00039793 | Completed | Phase 2 | Massage Therapy for Cancer-Related Fatigue | March 2001 | March 2004 |
| NCT00040365 | Completed | Phase 2 | Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer | June 2002 | June 2011 |
| NCT00040586 | Completed | Phase 2 | Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2 | ||
| NCT00055471 | Completed | Phase 2 | A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer | June 2003 | October 2005 |
| NCT00056654 | Completed | N/A | Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer | March 2003 | July 2004 |
| NCT00060528 | Completed | Phase 1/Phase 2 | Sequential Vaccinations in Prostate Cancer Patients | May 22, 2003 | June 8, 2009 |
| NCT00061035 | Completed | Phase 1 | Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma | April 2003 | |
| NCT00064610 | Completed | Phase 1/Phase 2 | Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancer | December 2002 | |
| NCT00070837 | Completed | Phase 1/Phase 2 | MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer | October 2003 | October 2004 |
| NCT00075192 | Completed | Phase 1/Phase 2 | CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer | March 2004 | March 2006 |
| NCT00080041 | Completed | Phase 1 | Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors | ||
| NCT00089609 | Completed | Phase 2 | Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer | April 19, 2005 | January 9, 2018 |
| NCT00096551 | Completed | Phase 1 | A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy | November 1, 2004 | July 25, 2011 |
| NCT00106301 | Completed | Phase 2 | Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228 | April 1, 2004 | September 1, 2006 |
| NCT00113984 | Completed | Phase 1 | Vaccine and Antibody Treatment of Prostate Cancer | June 8, 2005 | December 1, 2011 |
| NCT00120939 | Completed | Phase 1 | Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer | ||
| NCT00127465 | Completed | Phase 1/Phase 2 | Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants | November 2001 | July 2003 |
| NCT00137436 | Completed | Phase 1/Phase 2 | Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer | October 2005 | March 2010 |
| NCT00152789 | Completed | Phase 2 | Normal Prostate: Oxygenation of the Prostate Gland in Men Undergoing Prostate Biopsy | April 2001 | March 2008 |
| NCT00152919 | Completed | Phase 3 | Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapy | February 2004 | May 2009 |
| NCT00160953 | Completed | Phase 2 | Endorectal Coil Magnetic Resonance Images (ERC-MRI) | February 2005 | February 2010 |
| NCT00166426 | Completed | Phase 2 | Exisulind Versus Placebo After Surgical Removal of the Prostate | February 2003 | May 2008 |
| NCT00166478 | Completed | Phase 2 | Exisulind Prior to Radical Prostatectomy | April 2002 | October 2007 |
| NCT00177125 | Completed | Phase 3 | Evaluating the Effect of the VCD on Erectile Function and Penile Length Post RRP | January 2004 | January 2004 |
| NCT00177619 | Completed | Phase 3 | Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study) | May 2002 | December 2005 |
| NCT00182624 | Completed | Magnetic Resonance Imaging to Evaluate Prostate Cancer | February 2, 2004 | September 6, 2007 | |
| NCT00188513 | Completed | Phase 1/Phase 2 | Intensity Modulated Radiation Therapy - Prostate Cancer | May 2001 | April 4, 2017 |
| NCT00188695 | Completed | Phase 1/Phase 2 | Combidex USPIO - Ultra-small Superparamagnetic Iron Oxide | April 2004 | March 15, 2022 |
| NCT00188708 | Completed | N/A | Effect of Casodex on Tumour Hypoxia - Prostate Cancer | April 2001 | March 10, 2022 |
| NCT01377753 | Completed | Phase 2 | MR Image Guided Therapy in Prostate Cancer | August 12, 2011 | July 31, 2018 |
| NCT01423474 | Completed | N/A | Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time | January 2012 | August 2019 |
| NCT01441713 | Completed | Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer | September 2011 | June 2012 | |
| NCT01443026 | Completed | Phase 2 | The Effects of Lycopene on High Risk Prostatic Tissue | February 2006 | April 2009 |
| NCT01446731 | Completed | Phase 2 | Dendritic Cell Vaccination and Docetaxel for Patients With Prostate Cancer | October 2011 | August 2015 |
| NCT01553188 | Completed | Phase 2 | AMG 386 and Abiraterone for Advanced Prostate Cancer | February 8, 2012 | July 1, 2018 |
| NCT01565746 | Completed | Phase 1 | Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics Study of BAY88-8223 in Japanese Patients | March 2012 | April 2016 |
| NCT01576029 | Completed | Phase 2 | Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate Cancer | August 2012 | December 2013 |
| NCT01577836 | Completed | Medico-economic Comparison of Robot-assisted Radical Prostatectomy Versus Radical Prostatectomy Via Laparotomy | November 26, 2012 | March 22, 2021 | |
| NCT01605227 | Completed | Phase 3 | Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100 | July 2012 | March 2015 |
| NCT01618370 | Completed | Phase 3 | Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases | July 22, 2012 | February 28, 2016 |
| NCT01640262 | Completed | Evaluation of Modern MRI in the Diagnosis of Prostate Cancer in a Danish Setup | August 2011 | August 2014 | |
| NCT01641185 | Completed | Phase 2 | Ion Prostate Irradiation | May 2012 | December 2015 |
| NCT01681823 | Completed | Phase 2 | Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA | June 2013 | January 2020 |
| NCT01683994 | Completed | Phase 1/Phase 2 | Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer | September 7, 2012 | January 16, 2019 |
| NCT01711892 | Completed | N/A | Health Effects of Soccer Training in Men With Prostate Cancer Receiving Androgen Deprivation Therapy | March 2012 | December 2013 |
| NCT01717391 | Completed | Phase 2 | [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers | October 1, 2012 | April 30, 2017 |
| NCT01723475 | Completed | Phase 1 | First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer | November 2, 2012 | September 26, 2018 |
| NCT01759836 | Completed | Phase 2 | Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer | October 2012 | September 30, 2021 |
| NCT01796028 | Completed | Phase 2 | Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancer | January 2013 | May 31, 2018 |
| NCT01810770 | Completed | Phase 3 | Radium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone Metastasis | March 26, 2013 | September 25, 2017 |
| NCT01821404 | Completed | Phase 2 | Atorvastatin Before Prostatectomy and Prostate Cancer | August 2012 | May 2017 |
| NCT01929655 | Completed | Phase 2 | Japanese BAY88-8223 Monotherapy Phase II Study | September 30, 2013 | May 16, 2017 |
| NCT01934790 | Completed | Phase 1/Phase 2 | Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases | December 22, 2013 | April 12, 2017 |
| NCT01955863 | Completed | N/A | Outpatient Radical Prostatectomy - Surgical and Anesthetic Considerations | March 2011 | January 2012 |
| NCT01962324 | Completed | N/A | Dose Escalation With SIB to Intraprostatic/Lymphatic GTV in High Risk Prostate Cancer | March 2015 | May 9, 2023 |
| NCT01991275 | Completed | N/A | Intrathecal Morphine in Robot-assisted Prostatectomy | November 2013 | June 2014 |
| NCT02004418 | Completed | Phase 1/Phase 2 | A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland | March 2014 | September 2020 |
| NCT02014337 | Completed | Phase 1 | Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors | January 2014 | December 2017 |
| NCT02023697 | Completed | Phase 2 | Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone | March 10, 2014 | August 9, 2018 |
| NCT02034552 | Completed | Phase 2 | A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC) | March 7, 2014 | June 26, 2018 |
| NCT02043184 | Completed | N/A | Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR | March 2013 | July 2016 |
| NCT02043678 | Completed | Phase 3 | Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms | March 30, 2014 | February 8, 2024 |
| NCT02053389 | Completed | N/A | Testing Decision Aids About Early Stage Prostate Cancer | November 2010 | February 2014 |
| NCT02064946 | Completed | N/A | High-dose Vitamin D Supplementation for ADT-induced Side Effects | March 2014 | November 2016 |
| NCT02076503 | Completed | N/A | Pre-operative PET-MR of High Risk Prostate Cancer Patients for Assessment of Cancer Aggressiveness and Lymph Node Status | April 2014 | May 2015 |
| NCT02079025 | Completed | N/A | Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer | December 2013 | February 2018 |
| NCT02151097 | Completed | PRIME - PRostate Imaging for Margin Evaluation | November 2014 | June 2016 | |
| NCT02153918 | Completed | Phase 2 | Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy | May 31, 2014 | January 16, 2018 |
| NCT02156414 | Completed | Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate Cancer | March 2013 | August 2014 | |
| NCT02182063 | Completed | Phase 2 | A Study With BIBF 1120 in Patients With Hormone Refractory Prostate Cancer | November 2005 | |
| NCT02182219 | Completed | Phase 1 | Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer | November 2005 | |
| NCT02190279 | Completed | Early Phase 1 | 18F-DCFBC PET/CT in Prostate Cancer | July 12, 2014 | January 11, 2018 |
| NCT02217566 | Completed | Phase 2 | Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy | September 23, 2014 | October 26, 2018 |
| NCT02230059 | Completed | Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC) | July 2013 | May 2014 | |
| NCT02234115 | Completed | Phase 3 | Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma | August 2014 | January 5, 2017 |
| NCT02245282 | Completed | Contrast Enhanced MRI of the Prostate | February 10, 2017 | December 12, 2018 | |
| NCT02338700 | Completed | Phase 1/Phase 2 | Safety and Efficacy Study of Mix Vaccine in Prostate Carcinoma Patient | January 2015 | August 2015 |
| NCT02341677 | Completed | N/A | SmartTarget: BIOPSY | November 2014 | September 2016 |
| NCT02362464 | Completed | Phase 2 | Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 | May 12, 2015 | March 25, 2022 |
| NCT02363855 | Completed | Phase 1 | Phase 1 Dose Escalation Study of BAY 1841788 in Japanese Metastatic Castration-resistant Prostate Cancer (mCRPC) Subjects | February 23, 2015 | January 18, 2018 |
| NCT02364531 | Completed | A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting | September 30, 2014 | November 1, 2018 | |
| NCT02381236 | Completed | Phase 2 | G-202 in the Neoadjuvant Setting Followed by Radical Prostatectomy in Patients With Prostate Cancer | February 2016 | February 2017 |
| NCT02391025 | Completed | Early Phase 1 | Gallium-68 Citrate PET Used in Prostate Cancer | May 28, 2015 | June 15, 2023 |
| NCT02443571 | Completed | Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC) | January 2015 | June 2015 | |
| NCT02453009 | Completed | Phase 2 | Addition of Enzalutamide to First Line Docetaxel for Castration Resistant Prostate Cancer | October 2014 | April 2019 |
| NCT02475057 | Completed | Phase 4 | Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists | August 2015 | June 2019 |
| NCT02526602 | Completed | N/A | Preservation of Endopelvic Fascia: Effects on Postoperative Incontinence and Impotence. Randomized Clinical Trial. | August 2015 | September 2019 |
| NCT02546908 | Completed | A Registry of Participants With Prostate Cancer in Asia | September 9, 2015 | September 1, 2020 | |
| NCT02631681 | Completed | N/A | Supervised Group Based Exercise for Men With Prostate Cancer on Androgen Deprivation Therapy | August 2014 | September 2017 |
| NCT02632669 | Completed | N/A | Hemi-Ablative Prostate Brachytherapy | July 6, 2012 | August 31, 2018 |
| NCT02668276 | Completed | N/A | Engaging Newly Diagnosed Men About Cancer Treatment Options | April 2016 | August 2019 |
| NCT02677376 | Completed | Imaging Biomarkers to Validate Response in Enzalutamide-Treated mCRPC | June 27, 2016 | January 3, 2020 | |
| NCT02692976 | Completed | Phase 2 | Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients | September 2015 | March 6, 2019 |
| NCT02702908 | Completed | Second Primary Cancers in Patients With Castration Resistant Prostate Cancer | March 15, 2016 | October 20, 2017 | |
| NCT02710721 | Completed | N/A | Fasting and Nutritional Therapy in Patients With Advanced Metastatic Prostate Cancer | April 2016 | December 2022 |
| NCT02712320 | Completed | Phase 3 | Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mg | February 2016 | December 19, 2017 |
| NCT02718378 | Completed | Phase 1 | Evaluation of Safety and Efficacy of Estetrol in Healthy Men | March 2016 | February 2017 |
| NCT02744534 | Completed | Phase 2 | Targeted Fusion Biopsy of the Prostate | November 2015 | March 31, 2018 |
| NCT02772562 | Completed | Phase 2 | Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy | July 18, 2016 | April 29, 2024 |
| NCT02788409 | Completed | Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US | May 15, 2016 | May 9, 2018 | |
| NCT02813408 | Completed | A Study to Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer Participants | May 3, 2016 | March 21, 2018 | |
| NCT02833038 | Completed | N/A | Effect of Intravenous Magnesium During Robot Assisted Prostatectomy | April 2016 | April 2019 |
| NCT02854436 | Completed | Phase 2 | An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies | August 31, 2016 | August 16, 2023 |
| NCT02854982 | Completed | Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer | September 1, 2015 | January 1, 2018 | |
| NCT02919904 | Completed | Feasibility Study for the Assessment of Sleep Quality in Men With Prostate Cancer Starting ADT | July 2015 | September 2018 | |
| NCT02924766 | Completed | Phase 1 | A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE) | October 3, 2016 | July 19, 2019 |
| NCT02943824 | Completed | N/A | Machine-learning Optimization for Prostate Brachytherapy Planning | August 24, 2017 | September 4, 2018 |
| NCT02963675 | Completed | Incidence of Second Primary Malignancies in Prostate Cancer Patients With Bone Metastases - an Observational Retrospective Cohort Study in Sweden | November 15, 2016 | March 31, 2017 | |
| NCT03064308 | Completed | N/A | The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery | June 26, 2017 | July 27, 2018 |
| NCT03237416 | Completed | Phase 1 | Drug-drug-interaction Study to Assess the Effect of Darolutamide on the Pharmacokinetics of Probe Substrates of CYP3A4 and P-gp in Healthy Male Volunteers | August 2, 2017 | December 18, 2017 |
| NCT03241758 | Completed | Vascular Changes Of Patients Undergoing Laparoscopic Radical Prostatectomy | November 29, 2011 | August 2, 2017 | |
| NCT03261999 | Completed | Phase 3 | Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer | September 26, 2017 | February 1, 2019 |
| NCT03315260 | Completed | Treatment Satisfaction With Ra-223 in Japan | April 11, 2019 | March 20, 2023 | |
| NCT03365518 | Completed | N/A | Innovations in the Treatment of Sexual Health Post Prostate Cancer Treatment: Comparing Mindfulness vs. CBT | December 29, 2017 | November 30, 2020 |
| NCT03390127 | Completed | N/A | Effect of PEEP on Arterial Oxygen Partial Pressure in Elderly Patients With Lithotomy Position Using LMA Supreme™ | January 5, 2018 | March 21, 2018 |
| NCT03436745 | Completed | Phase 1 | The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females | January 22, 2019 | January 30, 2024 |
| NCT03481816 | Completed | Phase 1 | Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines | July 24, 2018 | March 9, 2021 |
| NCT03501173 | Completed | A Study of Participants With Advanced Prostate Cancer in Canada | April 12, 2018 | July 14, 2023 | |
| NCT03526562 | Completed | N/A | Exercise Prescription Dose for Castration Resistance Prostate Cancer Patients | January 15, 2018 | June 15, 2018 |
| NCT00001377 | Completed | Familial Prostate Cancer | December 1993 | December 2000 | |
| NCT03834506 | Completed | Phase 3 | Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921) | May 2, 2019 | July 18, 2023 |
| NCT03834519 | Completed | Phase 3 | Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010) | May 2, 2019 | January 27, 2024 |
| NCT03879486 | Completed | N/A | Infectious Outcomes of Povidone-iodine Rectal Cleansing Plus Formalin Disinfection of Needle During Prostate Biopsy | May 31, 2017 | July 24, 2019 |
| NCT03961321 | Completed | Stereotactic MR-guided Adaptive Radiation Therapy for Localized Prostate Cancer | August 25, 2016 | April 17, 2019 | |
| NCT04298112 | Completed | PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment | May 1, 2020 | May 1, 2023 | |
| NCT04425200 | Completed | Prevalence of HRR-related Genes Mutations and Prognosis in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients in Real World Setting | July 29, 2020 | December 18, 2020 | |
| NCT04523207 | Completed | Phase 2 | A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases | August 19, 2020 | October 25, 2023 |
| NCT04628988 | Completed | Phase 1 | A Study of CC-90011 and Comparators in Participants With Prostate Cancer | July 28, 2021 | May 26, 2023 |
| NCT04638049 | Completed | N/A | Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT) | August 25, 2020 | August 8, 2022 |
| NCT04693910 | Completed | N/A | Multimedia-based Hormonal Therapy Information Program for Patients With Prostate Cancer | May 13, 2019 | January 31, 2021 |
| NCT04838613 | Completed | Phase 3 | Study of Diagnostic Performance of [18F]CTT1057 in BCR | September 30, 2021 | November 23, 2023 |
| NCT04838626 | Completed | Phase 2/Phase 3 | Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection | September 7, 2021 | November 24, 2023 |
| NCT04839120 | Completed | Phase 1 | PK, PD, Tolerability and Safety of MDPK67b in Healthy Volunteers | February 21, 2017 | June 7, 2017 |
| NCT04839367 | Completed | Phase 1 | Positron Emission Tomography (PET) Imaging of Participants With Confirmed Prostate Cancer Using 64Cu-SAR-bisPSMA (PROPELLER) | July 13, 2021 | October 19, 2022 |
| NCT04983459 | Completed | PSMA PET/CT for Biochemical Recurrence Detection in Patients With Prostate Cancer | October 1, 2018 | December 31, 2020 | |
| NCT05441501 | Completed | Phase 1 | A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer | November 15, 2022 | March 31, 2024 |
| NCT05506735 | Completed | The Role of the Seven Sweeps in the Prevention of the Prostate Cancer Among Those With a Positive Family History | May 1, 2022 | August 17, 2022 | |
| NCT05834270 | Completed | N/A | Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH | May 1, 2022 | December 1, 2022 |
| NCT06072196 | Completed | A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC) | October 4, 2023 | February 27, 2024 | |
| NCT03173924 | Enrolling by invitation | Phase 2 | 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer | June 6, 2017 | June 30, 2027 |
| NCT02526797 | Enrolling by invitation | Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance | January 2013 | December 2026 | |
| NCT02952469 | Enrolling by invitation | Early Phase 1 | Biodistribution/Reproducibility Ga-68 PSMA-HBED-CC | July 14, 2016 | June 2023 |
| NCT03827616 | Enrolling by invitation | Phase 2 | Moderately Hypofractionated Radiotherapy for Prostate Cancer. | January 25, 2019 | February 1, 2030 |
| NCT03648359 | Enrolling by invitation | N/A | Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance | May 1, 2020 | January 2026 |
| NCT03523338 | No longer available | An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer | |||
| NCT04854369 | No longer available | 68Ga-PSMA-11 Patients With Newly Diagnosed and Recurrent Prostate Cancer (Firefly) | |||
| NCT01516762 | No longer available | Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases | |||
| NCT06209853 | Not yet recruiting | Role of F-18 PSMA in Prostate Cancer Patient | January 15, 2024 | April 1, 2025 | |
| NCT05574647 | Not yet recruiting | N/A | Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer | October 1, 2022 | January 31, 2026 |
| NCT04093375 | Not yet recruiting | N/A | Radical Prostatectomy Versus Radical Radiotherapy for Locally Advanced Prostate Cancer | November 1, 2019 | December 31, 2026 |
| NCT05755490 | Not yet recruiting | N/A | PROWESS (PROstate Cancer Wearables Exercise and Structured Supports): A Pilot Supportive Care Intervention | March 2023 | December 31, 2023 |
| NCT05670691 | Not yet recruiting | a Study of Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients Performing Radical Prostatectomy Without Biopsy | January 10, 2023 | March 1, 2025 | |
| NCT06282185 | Not yet recruiting | N/A | SUPERvised Three-month Exercise Program in MEN With Prostate cAncer Receiving Androgen-deprivaTioN thERapy | March 1, 2024 | May 1, 2025 |
| NCT05941104 | Not yet recruiting | The Effect of Frailty on Blood Biology Indicators, Quality of Life and Survival of Patients With Radical Prostatectomy | July 15, 2023 | December 31, 2025 | |
| NCT06457854 | Not yet recruiting | Real-life Experience in Brazil in Patients With Castration-resistant Prostate Cancer Treated With Olaparib+Abiraterone | July 20, 2024 | September 23, 2025 | |
| NCT02334579 | Recruiting | N/A | Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer | December 2014 | December 2024 |
| NCT02869594 | Recruiting | Institut Paoli Calmettes Prostate Cancer Database | January 2010 | December 2030 | |
| NCT02899312 | Recruiting | PSMA PET/CT for Assessment of Recurrent Prostate Cancer | March 16, 2017 | June 2026 | |
| NCT04898634 | Recruiting | Phase 1 | A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer | July 13, 2021 | November 15, 2025 |
| NCT05335967 | Recruiting | N/A | Effectiveness Evaluation of a Self-management Program for Prostate Cancer Survivors | May 20, 2022 | July 31, 2024 |
| NCT05413850 | Recruiting | Phase 1/Phase 2 | Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection | July 20, 2022 | October 27, 2026 |
| NCT04557059 | Recruiting | Phase 3 | A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer | November 12, 2020 | August 27, 2029 |
| NCT06379880 | Recruiting | N/A | Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution | April 25, 2024 | February 25, 2025 |
| NCT06136650 | Recruiting | Phase 3 | A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) | December 18, 2023 | December 2, 2030 |
| NCT06056830 | Recruiting | Phase 3 | Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy | November 30, 2023 | February 2025 |
| NCT04521894 | Recruiting | The Application Value of 18F-prostate-specific Membrane Antigen PET/CT in Prostate Cancer | August 22, 2021 | August 31, 2023 | |
| NCT02138721 | Recruiting | N/A | Local Treatment With RP for Newly-diagnosed mPCa | June 28, 2018 | December 31, 2024 |
| NCT05616650 | Recruiting | Phase 2 | Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor | October 19, 2023 | December 1, 2028 |
| NCT05633160 | Recruiting | Phase 1/Phase 2 | 64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT) | June 15, 2023 | May 2026 |
| NCT05714774 | Recruiting | N/A | Evaluation of Different Methods of Ultrasound Image Analysis for Real-time Monitoring of HIFU Prostate Cancer Treatment | March 9, 2023 | March 14, 2025 |
| NCT05720130 | Recruiting | Phase 1/Phase 2 | Dose Escalation and Efficacy Study of 212Pb-ADVC001 in Patients With Metastatic Castration Resistant Prostate Cancer. | March 15, 2023 | June 2024 |
| NCT02102477 | Recruiting | N/A | Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer | October 2014 | December 2045 |
| NCT04428788 | Recruiting | Phase 1 | Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer | June 22, 2020 | December 27, 2026 |
| NCT05958004 | Recruiting | The Application Value of Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA Grey Area Prostate Cancer | June 15, 2023 | May 20, 2025 | |
| NCT05765500 | Recruiting | Phase 2 | RecoverPC: Relugolix vs GnRH Agonist in Quality of Life | February 12, 2024 | January 1, 2026 |
| NCT06242119 | Recruiting | Clinical Application of the J-PET Scanner Prototype | March 7, 2024 | October 14, 2024 | |
| NCT05787145 | Recruiting | N/A | ComCancer: Use of Let's Discuss Health Website by Patients With Prostate Cancer Undergoing Radiation Oncology Treatment | March 10, 2021 | November 2024 |
| NCT04964271 | Recruiting | Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants | September 9, 2021 | July 2023 | |
| NCT00756665 | Recruiting | Prostate Active Surveillance Study | July 2008 | September 2032 | |
| NCT06433063 | Recruiting | N/A | Effect of Hypoxia on FMISO PET to Response to Lu-177 PSMA Treatment | February 1, 2024 | February 1, 2026 |
| NCT04295447 | Recruiting | Phase 2 | Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy | December 10, 2020 | May 31, 2027 |
| NCT04967001 | Recruiting | N/A | 68Ga-PSMA PET in the Prostate Cancer | June 1, 2021 | December 31, 2024 |
| NCT06253065 | Recruiting | Prospective Validation of Pathology-based Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in Prostate Cancer | January 12, 2024 | December 2025 | |
| NCT00923221 | Recruiting | Collection of Blood From Patients With Prostate Cancer | February 28, 2007 | ||
| NCT04833426 | Recruiting | Phase 3 | Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy | December 12, 2022 | December 2027 |
| NCT04790968 | Recruiting | N/A | Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients | April 28, 2021 | June 2024 |
| NCT05851547 | Recruiting | Phase 2 | Dose Escalation For INtraprostatic LEsions | November 23, 2023 | June 2028 |
| NCT04017104 | Recruiting | Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging | November 1, 2019 | August 1, 2024 | |
| NCT01913106 | Recruiting | Phase 1/Phase 2 | HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer | June 2007 | December 2028 |
| NCT01834001 | Recruiting | Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy | November 13, 2013 | ||
| NCT05123391 | Recruiting | N/A | Randomized Pilot Study of Radiosurgery for the Treatment of Non-metastatic Prostate Cancer | June 22, 2021 | June 22, 2024 |
| NCT06136598 | Recruiting | Phase 1 | A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001) | January 30, 2024 | October 14, 2027 |
| NCT05228197 | Recruiting | Imperial Prostate 6 - Cancer Histology Artificial Intelligence Reliability Study. | March 11, 2022 | December 31, 2024 | |
| NCT03805919 | Recruiting | Men at High Genetic Risk for Prostate Cancer | March 27, 2019 | January 1, 2039 | |
| NCT04644770 | Recruiting | Phase 1 | A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer | November 12, 2020 | December 26, 2025 |
| NCT05264337 | Recruiting | Lymphedema After Urologic Surgery | March 14, 2022 | January 2030 | |
| NCT05918263 | Recruiting | N/A | Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Trial | January 1, 2024 | March 31, 2027 |
| NCT05872503 | Recruiting | Study of Rates of Prostate Cancer Diagnosis in Men of African Ancestry Using MRI and MRI Guided Biopsy | March 20, 2024 | December 1, 2029 | |
| NCT05902637 | Recruiting | N/A | The Efficacy Of Mapping For Cognitive Prostate Biopsy | March 1, 2023 | September 1, 2023 |
| NCT05266313 | Recruiting | N/A | Contributions of a Paramedical Approach in the Prevention and Treatment of Side Effects Associated With Radical Prostatectomy | March 31, 2022 | March 31, 2025 |
| NCT00999960 | Suspended | N/A | Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator | February 2010 | December 2017 |
| NCT00450008 | Terminated | Phase 2 | Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer | December 2006 | September 2008 |
| NCT04907227 | Terminated | Phase 3 | Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)-China Extension | September 23, 2020 | July 18, 2023 |
| NCT02771769 | Terminated | Analysis of Cell-free DNA (cfDNA) in Men With Elevated PSA Levels | January 2016 | January 1, 2020 | |
| NCT05295927 | Terminated | Phase 1 | A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) | March 23, 2022 | September 30, 2022 |
| NCT00861471 | Terminated | Phase 1/Phase 2 | Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer | May 2005 | May 2010 |
| NCT03066154 | Terminated | Phase 1 | Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer | September 2016 | August 2022 |
| NCT01365143 | Terminated | Phase 4 | Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy | May 2011 | February 2014 |
| NCT01420965 | Terminated | Phase 2 | Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer | September 2012 | December 2016 |
| NCT01450683 | Terminated | Phase 2 | Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy | September 2010 | April 2011 |
| NCT01335204 | Terminated | Phase 1/Phase 2 | Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer | June 2011 | March 2013 |
| NCT01522443 | Terminated | Phase 3 | Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer | March 2012 | January 13, 2015 |
| NCT01545882 | Terminated | Phase 2 | A Phase II Study of Degarelix in the Management of Non-Metastatic Hormone-Refractory Prostate Cancer | May 2011 | July 2013 |
| NCT03553732 | Terminated | An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital | July 1, 2018 | September 29, 2019 | |
| NCT00705822 | Terminated | Phase 3 | Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer | August 2006 | July 2009 |
| NCT00676650 | Terminated | Phase 3 | Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy | July 2008 | December 2011 |
| NCT01647789 | Terminated | Phase 1 | A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer | December 4, 2012 | February 3, 2016 |
| NCT01132404 | Terminated | Phase 1/Phase 2 | Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 | November 2010 | December 2011 |
| NCT00672009 | Terminated | Phase 2 | A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer | April 2008 | August 2012 |
| NCT00593853 | Terminated | Phase 2 | Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapy | January 2008 | May 2011 |
| NCT01816048 | Terminated | Phase 2 | NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis | May 2013 | November 2016 |
| NCT01857817 | Terminated | Phase 2 | Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer | June 2013 | April 2016 |
| NCT01918605 | Terminated | N/A | Protection of Rectum From High Radiation Doses Using a Spacer | June 2013 | October 2017 |
| NCT01076751 | Terminated | Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients | February 2010 | October 2010 | |
| NCT04033328 | Terminated | Phase 1 | Study of ORIC-101 in Combination With Enzalutamide | October 28, 2019 | December 4, 2023 |
| NCT01976962 | Terminated | N/A | Functional MR-guided Stereotactic Body Radiation Therapy of Prostate Cancer | January 10, 2018 | November 25, 2021 |
| NCT00521781 | Terminated | Phase 2 | Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer | August 2007 | October 2008 |
| NCT01995058 | Terminated | Phase 2 | Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer | December 2013 | November 2014 |
| NCT04085991 | Terminated | Phase 2 | Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate Cancer | July 31, 2020 | January 15, 2023 |
| NCT00521274 | Terminated | Phase 2 | Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancer | August 2007 | August 2008 |
| NCT00514917 | Terminated | Phase 3 | A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA) | July 2007 | September 2012 |
| NCT00050687 | Terminated | Phase 1/Phase 2 | Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies | June 2001 | March 2005 |
| NCT01020305 | Terminated | Phase 1/Phase 2 | Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer | October 2009 | April 2012 |
| NCT02125617 | Terminated | Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate Cancer | January 2014 | February 2017 | |
| NCT00477087 | Terminated | Phase 2 | Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer | July 2006 | January 2010 |
| NCT00048659 | Terminated | Phase 2 | YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy | June 2004 | |
| NCT00976508 | Terminated | Phase 1 | Figitumumab Combined With Pegvisomant For Advanced Solid Tumors | November 2009 | October 2012 |
| NCT02284971 | Terminated | Phase 1 | Pilot Study of SBRT and CDX-1127 in Prostate Cancer | November 2014 | April 7, 2016 |
| NCT00448097 | Terminated | Phase 2 | Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy | February 2007 | August 2008 |
| NCT02362451 | Terminated | Phase 2 | Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer | July 10, 2015 | February 13, 2020 |
| NCT00447473 | Terminated | Phase 2 | Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer | July 2006 | September 2008 |
| NCT00383487 | Terminated | Phase 2 | A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer | March 2005 | July 2007 |
| NCT00381836 | Terminated | Phase 2/Phase 3 | Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer | October 2006 | February 2007 |
| NCT00930748 | Terminated | Evaluation of MRI for Prostate Cancer | November 2008 | June 2011 | |
| NCT02506114 | Terminated | Phase 2 | Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer | October 6, 2016 | April 22, 2020 |
| NCT02508636 | Terminated | Phase 2 | Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer | December 22, 2015 | August 31, 2020 |
| NCT00040170 | Terminated | Phase 2 | Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer | May 2002 | |
| NCT02560051 | Terminated | Phase 2 | Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer | November 2015 | September 14, 2017 |
| NCT02584400 | Terminated | Phase 2 | Tumor Hypoxia With HX4 PET in Several Diseases | May 2016 | May 2017 |
| NCT02606123 | Terminated | Phase 1/Phase 2 | Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer | October 2015 | December 2017 |
| NCT02616185 | Terminated | Phase 1 | A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR) | December 30, 2015 | February 23, 2021 |
| NCT03119857 | Unknown status | Phase 3 | Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14 | February 2009 | April 2023 |
| NCT04836949 | Unknown status | N/A | Verification of Shear Wave Elastography for DEtection of Prostate Cancer | May 3, 2021 | February 1, 2024 |
| NCT00452556 | Unknown status | Phase 2 | The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study | May 2007 | February 2017 |
| NCT03101176 | Unknown status | N/A | Multiparametric Ultrasound Imaging in Prostate Cancer | September 7, 2017 | September 1, 2022 |
| NCT03094897 | Unknown status | Early Phase 1 | Clinic Study of 18F-Al-NOTA-MATBBN in Cancer Diagnostics | April 20, 2017 | December 31, 2020 |
| NCT03021200 | Unknown status | N/A | Laser Fluorescence in Cancer Surgical Treatment | July 12, 2016 | December 10, 2020 |
| NCT04573179 | Unknown status | Effectiveness of 68Ga-PSMA PET/MRI for Improving the Detection of csPCa in Lesions With PI-RADS Score 3 | July 1, 2020 | July 1, 2021 | |
| NCT02950064 | Unknown status | Phase 1 | A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations | September 2016 | August 2020 |
| NCT02233725 | Unknown status | Phase 1 | MRI / Ultrasound Fusion With Contrast-Enhanced Ultrasound Guidance | July 2014 | December 2015 |
| NCT02940977 | Unknown status | Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique | October 1, 2016 | March 30, 2019 | |
| NCT02672657 | Unknown status | Determinants of Quality Of Life in AGEd Cancer Patients | February 2016 | December 2019 | |
| NCT04101305 | Unknown status | Measurement of Circulating Tumor Cells in Prostate Cancer | September 2019 | December 2021 | |
| NCT05068180 | Unknown status | Phase 4 | Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients | October 5, 2021 | April 10, 2022 |
| NCT04248621 | Unknown status | Phase 4 | Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients | January 23, 2020 | December 31, 2022 |
| NCT03533998 | Unknown status | Biomarkers in Prostate Cancer Treated With SRP Following Failure of FAT | May 31, 2018 | September 30, 2018 | |
| NCT03479359 | Unknown status | Learning Curve of Digital Rectal Examination for Prostate Cancer Among Internship | February 26, 2018 | February 26, 2019 | |
| NCT00185029 | Unknown status | Phase 4 | MR-Lymphography and Lymph Node Staging in Prostate Cancer | April 2002 | August 2005 |
| NCT03428087 | Unknown status | Prostate Impendance Test Project | July 1, 2017 | June 30, 2018 | |
| NCT03421015 | Unknown status | Genetic Analysis of Prostate Cancer to Identify Predictive Markers of Disease Relapse or Metastatic Evolution | May 1, 2017 | July 2020 | |
| NCT02563691 | Unknown status | Phase 1/Phase 2 | Stereotactic Radiotherapy for Oligometastatic Prostate Cancer | November 2014 | December 2022 |
| NCT05022160 | Unknown status | Early Phase 1 | Preventing Catheter Related Bladder Discomfort (CRBD) With Bilateral Pudendal Nerve Block | August 10, 2021 | November 10, 2021 |
| NCT02283346 | Unknown status | Phase 2 | Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II Trial | November 2014 | November 2017 |
| NCT02600481 | Unknown status | N/A | Impacts of Different Pressure Pneumoperitoneum on Myocardial and Pulmonary Injuries After Robot-assisted Surgery | January 2016 | December 2018 |
| NCT02290561 | Unknown status | N/A | SmartTarget THERAPY | December 2014 | October 2015 |
| NCT00573820 | Unknown status | Phase 1 | Far Infrared Radiation Treatment for Prostate Cancer | January 2006 | December 2008 |
| NCT03677414 | Unknown status | Analysis of Androgene Receptors Axis and DNA Damage Repair Genes in Patients With Prostate Cancer | September 10, 2018 | August 31, 2021 | |
| NCT02831920 | Unknown status | N/A | CEUS Targeted Biopsies Compared to mpMRI Targeted and Systematic Biopsies for the Detection of Prostate Cancer | December 7, 2015 | December 2019 |
| NCT03600766 | Unknown status | Phase 2 | Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study | August 1, 2018 | January 1, 2020 |
| NCT02631616 | Unknown status | Phase 1 | Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATET | February 2016 | March 2018 |
| NCT03987737 | Unknown status | N/A | Rectal Gas Removal Through Small Catheter Placement Prior to MRI of the Prostate | August 2019 | October 2020 |
| NCT03587285 | Unknown status | Phase 1/Phase 2 | A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate Cancer | September 23, 2018 | July 31, 2021 |
| NCT02344667 | Unknown status | Phase 2 | Feasibility Study of Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer: Cyberknife vs. VMAT | March 2015 | |
| NCT00546039 | Unknown status | Phase 2 | Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer | April 2007 | January 2009 |
| NCT02668718 | Unknown status | Phase 3 | Adjuvant Radiation Therapy vs. Watchful Waiting Following Radical Prostatectomy in High Risk Prostate Cancer | March 2004 | December 2017 |
| NCT00906269 | Unknown status | Phase 4 | Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancer | July 2009 | January 2021 |
| NCT00121095 | Unknown status | Phase 1/Phase 2 | Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer | July 2005 | June 2008 |
| NCT02651896 | Unknown status | Hypofractionated Intensity Modulated and Image Guided Radiotherapy for Localized Prostate Cancer | December 20, 2015 | December 2019 | |
| NCT01173952 | Unknown status | Quality of Life in Men Undergoing Robotic Assisted Laparoscopic Radical Prostatectomy Versus Radical Retropubic Prostatectomy | August 2010 | January 2014 | |
| NCT02905201 | Withdrawn | A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) | September 2016 | April 2018 | |
| NCT02260349 | Withdrawn | Phase 3 | Interest of Indocyanine Green in Neoplastic Prostatic Tissue | April 2014 | February 2016 |
| NCT02621190 | Withdrawn | Phase 2 | Cabazitaxel in mCRPC Patients With AR-V7 Positive CTCs | February 2016 | June 2019 |
| NCT00482157 | Withdrawn | N/A | Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance | February 2007 | November 2007 |
| NCT02647983 | Withdrawn | Phase 1 | Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) Injection | April 2016 | October 2019 |
| NCT01981668 | Withdrawn | Phase 1 | The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivation | ||
| NCT01802307 | Withdrawn | Phase 2 | Focal Therapy for Prostate Cancer | February 2013 | March 2018 |
| NCT02430649 | Withdrawn | N/A | Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms | January 1, 2015 | January 1, 2025 |
| NCT00110526 | Withdrawn | Phase 1 | Gene Therapy for Prostate Cancer That Returns After Radiation Therapy | April 2005 | April 2008 |
| NCT01685489 | Withdrawn | Phase 1 | A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer | May 2013 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D011471